Author

Shihab Kochumon

Vice Provost for Research & Professor of Pharmacology Albany College of Pharmacy and Health Sciences - Cited by 37,979 - cardiovascular pharmacology - hematology/oncology - drug discovery/drug development - vascular diseases - neuropharmacology

Biography

 Shihab Kochumon currently works at Immunology & Innovative Cell Therapy Unit from Dasman Diabetes Institute (DDI), Kuwait. Shihab Kochumon is a Reader with a joint appointment at Immunology and Innovative Cell Therapy Unit, Dasman Diabetes Institute, Kuwait. She holds a Career Development Fellowship from the Cancer Research UK. She leads projects in genetic, molecular and cancer epidemiology
Title
Cited by
Year
Necroptosis in Alzheimer’s disease: Potential therapeutic target
R Richard, S MousaBiomedicine & Pharmacotherapy 152, 113203, 2022202
10
2022
Curcumin and thymoquinone combination attenuates breast cancer cell lines’ progression
AA Saddiq, AH El-Far, SA Mohamed, OA Almaghrabi, SA MousaIntegrative Cancer Therapies 21, 15347354221099537, 2022202
6
2022
Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression
AA Saddiq, AH El-Far, SA Mohamed Abdullah, K Godugu, OA Almaghrabi, ...Frontiers in Pharmacology 13, 9399, 2022202
6
2022
Three-dimensional (3D) cell culture: A valuable step in advancing treatments for human hepatocellular carcinoma
AF Khafaga, SA Mousa, L Aleya, MM Abdel-DaimCancer Cell International 22 (1), 1-11, 2022202
4
2022
Photochemoprevention of ultraviolet Beam Radiation-induced DNA damage in keratinocytes by topical delivery of nanoformulated Epigallocatechin-3-gallate
TA Salaheldin, VM Adhami, K Fujioka, H Mukhtar, SA MousaNanomedicine: Nanotechnology, Biology and Medicine , 102580, 2022202
4
2022
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
SA Loutfy, MH Elberry, KY Farroh, HT Mohamed, AA Mohamed, ...International Journal of Nanomedicine 17, 2891-2892, 2022202
3
2022
Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
A Elfadadny, RF Ragab, R Hamada, SK Al Jaouni, J Fu, SA Mousa, H AliToxicology and Applied Pharmacology, 116405, 20220
3
2023
Pomegranate nanoparticle mitigates cisplatin-induced testicular toxicity and improves cisplatin anti-cancer efficacy in Ehrlich carcinoma model
M Qari, S Harakeh, IO Akefe, SH Saber, R Al-Raddadi, ZY Abd Elmageed, ...Journal of King Saud University-Science 35 (4), 10631, 030
2
2023
Composition and method for dual targeting in treatment of neuroendocrine tumors
S Mousa, M Rajabi, OO KarakusUS Patent 11,351,137, 0
2
2022
Future regenerative medicine developments and their therapeutic applications
AE Altyar, A El-Sayed, A Abdeen, M Piscopo, SA Mousa, A Najda, ...Biomedicine & Pharmacotherapy 158, 114131, 030
2
2023
Photochemical effect of silver nanoparticles on flesh fly larval biological system
MM Ali, MA Ramadan, NA Ghazawy, A Afify, SA MousaActa Histochemica 14 (3), 151871, 0
2
2022
Genetic Interpretation of the Impacts of Honokiol and EGCG on Apoptotic and Self-Renewal Pathways in HEp-2 Human Laryngeal CD44high Cancer Stem Cells
R Ashry, M Elhussiny, H Abdellatif, O Elkashty, HA Abdel-Ghaffar, ...Nutrition and Cancer 74 (6), 252-273, 2022202
1
2022
Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas
IE Wang, S Yi, RC Block, SA MousaNutrition Research Reviews 35 (2), 295-307, 2022202
1
2022
Preclinical evaluation of triiodothyronine nanoparticles as a novel therapeutic intervention for resuscitation from cardiac arrest
BR Weil, SE Allen, T Barbaccia, K Wong, AM Beaver, EA Slabinski, ...Resuscitation 86, 09735, 2023202
1
2023